NCT06245746View on ClinicalTrials.gov

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

PHASE1RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
Acute Myeloid LeukemiaNeutropeniaAnemiaThrombocytopeniaInfectionsBleeding
Interventions
BIOLOGICAL

umbilical cord derived mesenchymal stem cells exosomes (UCMSC-Exo)

UCMSC-Exo will be infused intravenously.

Trial Locations (1)

430000

RECRUITING

Wuhan Union Hospital, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT06245746 - UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter